Overview
To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures
Eligibility
Inclusion Criteria:
- Subjects completed Study YKP3089C035 by SK Life Science.
Exclusion Criteria:
- Subjects that have previously discontinued for any reason from the Core study (YKP3089C035).
- Any significant changes to the medical history of the subject that in the opinion of the investigator, could affect the safety of the subject.